Grow Therapy has secured $150 million in Series D funding to expand its mental health platform and strengthen connections between insurers, employers, and healthcare providers. The round was led by TCV and Goldman Sachs Alternatives Growth Equity, with participation from new investors BCI and Menlo Ventures, alongside existing backers Sequoia Capital, SignalFire, and Transformation Capital.
Since launching five years ago, Grow Therapy has served more than two million people and facilitated roughly 10 million therapy and medication management appointments, including seven million visits in 2025 alone. The platform now works with more than 125 insurance partners, expanding access to care for about 220 million people across the U.S.
The funding will also support expansion into employer and healthcare system partnerships while advancing technology used by clinicians and patients. Jay Hoag, Founding General Partner at TCV, stated, “We are excited to continue to partner with Grow on the journey to provide access to, and improvement of, quality mental health care.” The company has introduced several platform features that have reduced provider documentation time by nearly 70% and mobile tools that help patients track progress between sessions.
Grow Therapy plans to roll out a redesigned employee mental health benefit, enabling workers to transition seamlessly from employee assistance programs to insurance coverage without changing therapists. Julie Harris, the company’s Vice President of Enterprise Partnerships, said, “Grow offers a rigorously vetted network that delivers measurable mental health improvements in a model designed to complement, not compete with, existing health plan benefits.”
